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Edited by Laszlo NagyAbstract To investigate the molecular consequence of loading
free cholesterol into macrophages, we conducted a large-scale
gene expression study to analyze acetylated-LDL-laden foam
cells (AFC) and oxidized-LDL-laden foam cells (OFC) induced
from human THP-1 cell lines. Cluster analysis was performed
using 9600-gene microarray datasets from time course experi-
ment. AFC and OFC shared common expression proﬁles; how-
ever, there were suﬃcient diﬀerences between these two
treatments that AFC and OFC appealed as two separate entities.
We identiﬁed 80 commonly upregulated genes and 48 commonly
downregulated genes in AFC and OFC. Functional annotation of
the diﬀerentially expressed genes indicated that apoptosis, extra-
cellular matrix, oxidative stress, and cell proliferation was dereg-
ulated. We also identiﬁed 87 diﬀerentially expressed genes
unique for AFC and 31 genes for OFC. The uniquely expressed
genes of AFC are associated with kinase activity, ATP binding
activity, and transporter activity, while unique genes for OFC
are associated with cell signaling and adhesion. To validate the
hypothesis that oxidative stress is a common feature for AFC
and OFC, we performed a cluster analysis employing the genes
related to oxidative stress, but we were unable to distinguish
AFC from OFC in this manner. We performed real-time RT-
PCR and ELISA on foam cells to examine the transcripts and
secreted protein of interleukin 1 beta (IL1b). IL1b was rapidly
induced in foam cells, but for AFC both RNA level and protein
level dropped immediately and was attenuated. To detect levels
of reactive oxygen species in foam cells we conducted hydroethi-
dine staining and observed high levels of superoxide anion. We
conclude that loading free cholesterol induces high levels of
superoxide anion, increases oxidative stress, and triggers a tran-
sient inﬂammatory response in macrophages.
 2006 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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The pathogenesis of cardiovascular disease, which is the lead-
ing cause of death in developed countries, occurs initially
through atherosclerosis [1,2]. High levels of low-density lipo-
proteins (LDL) and oxidative stress are primary risk factors
for the development of atherosclerosis [3–6]. Foam cells, which
are the hallmark of an early atherosclerotic lesion, form as a re-
sult of a macrophage internalizing oxidized LDL (ox-LDL)*Corresponding author. Fax: +886 3 5753956.
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doi:10.1016/j.febslet.2005.12.102through a scavenger receptor without feedback control
[7–10]. These foam cells initiate an increase in oxidative stress
and stimulate proliferation of smooth muscle cells in vitro
[11–16].
The genetic consequences of macrophages taking up ox-
LDL have been investigated broadly. Ox-LDL induces pro-
inﬂammatory genes, activates PPARc, and inﬂuences the
expression of downstream genes. The induced macrophages se-
crete interleukin-1 beta (IL1b), which is a potent growth factor
for smooth muscle cells (SMCs) [17]. IL1b may stimulate the
SMCs to over-express platelet-derived growth factor (PDGF),
which may cause migration and proliferation of the SMCs.
Ox-LDL is toxic to macrophages; it causes the apoptosis and
necrosis of foam cells and the subsequent release of their cellu-
lar contents, which may compose the necrotic core found in
advanced lesions [18–21]. Large-scale surveys of the gene
expression in ox-LDL-loaded foam cells have been performed
on genome-wide scale [22–31]. Molecular markers are impli-
cated in the cell growth, survival, migratory, inﬂammatory,
and matrix remodeling of macrophages.
Oxidativemodiﬁcation transformsLDL into a powerful path-
ogen, but it is not clear whether the oxidative stress of foam cells
is due to the oxidative modiﬁcation of ox-LDL or to the cellular
processing that follows the internalization through binding to
the scavenger receptor. AcetylatedLDL (ac-LDL), a non-oxida-
tively modiﬁed LDL, is readily taken up by macrophages,
through a scavenger receptor, to generate foam cells [32–36].
Ac-LDL induces apoptosis and also inﬂammatory response in
macrophages [37]. It is likely, but yet to be proven, that the inter-
nalized free cholesterol, analogous to oxidizedLDL, triggers cel-
lular pathways that lead to the increase in oxidative stress.
To evaluate the contribution of internalized cholesterol to
the atherosclerotic behavior of foam cells, we conducted
large-scale expression proﬁling of foam cells derived from both
ox-LDL and ac-LDL [38]. Our results provide insights into the
molecular mechanisms that distinguish the intracellular and
extracellular oxidative events.2. Materials and methods
DMEM, FBS, antibiotics, and all other tissue culture reagents were
obtained from GIBCO. CuSO4, KBr, thiobarbituric acid, trichloroace-
tic acid, and other common chemicals were purchased from Sigma or
Merck.
2.1. Isolation of LDL and copper-mediated oxidation of LDL
LDL, in the density range 1.019–1.063, was isolated from human
plasma through ultracentrifugation as described [39]; the typical
protein concentration was 5 mg/ml. Copper-mediated oxidation was
performed, as described in Mao et al. [40], through the addition ofation of European Biochemical Societies.
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at 37 C for 16 h. The reaction was terminated upon the addition of
excess EDTA.2.2. Human macrophage cell lines THP-1
Human THP-1 cells were added to six-well tissue culture plates con-
taining glass cover slips at 2 · 106 cells/well in DMEM containing 10%
fetal bovine serum and 100 lg/ml penicillin; they were cultured for 4 h
at 37 C in an incubator containing 5% CO2 at 90% humidity. The
non-adherent cells were removed and the monolayers were then placed
in DMEM containing 10% fetal bovine serum and supplemented with
100 lg/ml ox-LDL or ac-LDL. Foam cell formation was monitored by
Oil Red O staining [41]. Monolayers of macrophages on glass cover
slips were ﬁxed with 10% formaldehyde in PBS (pH 7.4) for 10 min
at room temperature, stained with Oil Red O, counterstained for
10 min with hematoxylin, and then examined under a microscope.2.3. Microarray analysis
Inconsistent handling of microarray experiments frequently gener-
ates data that is diﬃcult to process, especially for the time course
experiment. We carefully initiated all experiments at the same starting
point. Once a sample was harvested, we proceeded to cDNA synthesis
and stored the labeled cDNA at 80 C until use. All microarray
hybridizations were conducted at the same time.
All microarray procedures – including PCR ampliﬁcation, spotting,
post-spotting processing, RNA extraction, probe preparation, hybrid-
ization, and post-hybridization experiments – were performed in a
dust/climate controlled laboratory. Microarray design, experimental
procedures, data processing, and data presentation were carefully per-
formed according to the MIAME guidelines [42]. A microarray con-
sisting of 9600 sequence-veriﬁed human cDNA was utilized in this
current study [43].
The microarray experiment for each time point was performed in
duplicate. Total RNA was extracted using the protocol supplied with
the TRI reagent (Molecular Research Center, Inc., USA). The quality
of the RNA was examined through agarose gel electrophoresis; the
OD 260/280 ratio was >1.8. In a typical labeling reaction, total RNA
(0.5–10 lg) was annealed with polydT(15) (0.5 lg) in a total volume
of 20 lL. The cDNA synthesis was performed in 1· Superscript RT
II reaction buﬀer (50 lL) containing annealed RNA, 0.5 mM each of
dATP, dGTP, and dTTP, 40 lM of dCTP and Cy3-dCTP or Cy-5-
dCTP (Roche, USA), 10 mM DTT, 1 U of RNasin (Invitrogen,
USA), and 50 U of Superscript RT II (Invitrogen). The mixture was
incubated in the dark for 90 min at 42 C and the reaction was termi-
nated through heating at 95 C for 5 min. The RNA was degraded
through the addition of 3 N NaOH (5.5 lL) and incubation at 50 C
for 30 min. The mixture was neutralized upon the addition of 3 M ace-
tic acid (5.5 lL) and ﬁlter-puriﬁed through a Microcon YM-100 (Ami-
con Co., USA) to a ﬁnal volume of 30 lL. Using a 50-mL conical tube,
the microarray was prehybridized at 42 C for 1 h in a prehybridization
buﬀer (30 ml) containing 25% formamide, 5· SSC, 0.1% SDS, and
0.1 mg/mL BSA. The labeled probe was mixed with polydA(10)
(20 lg) and human Cot-1 DNA (20 lg; Invitrogen) and then denatured
at 95 C for 5 min. The denatured probe was dried and suspended in the
prehybridization buﬀer (20 lL). Hybridization was performed in a
Corning hybridization chamber and incubated at 42 C for 12–16 h.
The slide was washed twice with 2· SSC and 0.1% SDS (30 ml) for
5 min at room temperature, followed by three washes (30 ml each;
20 min each) with 0.1· SSC and 0.1% SDS at 42 C. All washing proce-
dures were performed through gentle shaking in 50-mL conical tubes.
Fluorescence scanning was performed using an Axon Genepix 4000B.
The ﬂuorescent image was processed by GenePix Pro 3.0 to obtain
the raw expression dataset. The mean intensity and mean background
intensity were utilized for data processing; the global array intensity
was employed for normalization controls. Non-linear normalization
was performed using locally weighted linear regression (lowess) [44].
Logarithmic ratios (base 2) were calculated accordingly. Duplicated
data were averaged to obtain single dataset for each time point.2.4. Statistical analysis for microarray datasets
Diﬀerentially expressed genes of microarray datasets were derived
ﬁrstly by signiﬁcance analysis of microarrays (SAM) [45]. The P-values
corresponding to each gene were obtained by a standard t-test. Themultiplicity of P-values due to the consequence of performing statisti-
cal tests on many genes in parallel was resolved by SAMmethod. SAM
assigns a score to each gene based on change in gene expression relative
to standard deviation of measurements. SAM performs permutation
for repetitive measurement to estimate false discovery rate (FDR). In
the current study, we adjusted the gene expression threshold that gave
mean number of false discovery to less than one gene. Additionally,
signiﬁcantly expressed genes derived from SAM were further ﬁltered
by the criterion set by twice of the standard deviation calculated from
the averaged dataset.
2.5. Real-time reverse transcription polymerase chain reaction
(RT2 PCR)
Real-time PCR analysis was performed, according to the manufac-
turer’s instructions, using an iQ SYBR green supermix (Bio-Rad,
USA) and the speciﬁc primer pairs for selected genes and the primer
pairs for ribosomal protein L18 as the reference gene. The threshold cy-
cle number (Ct) was measured using the iCycler and its associated soft-
ware (Bio-Rad; [46]). Relative transcript quantities were calculated
using theDDCt methodwith ribosomal protein L18 as the reference gene
ampliﬁed from the samples. DCt is the diﬀerence in the threshold cycles
of the sample mRNAs relative to those of the ribosomal protein L18
mRNA. DDCt is the diﬀerence between the values of DCt of the THP-
1 cell control and the foam cells. Values for fold-induction were calcu-
lated as 2DDCt . RT2PCR was performed in triplicate for each time point.
2.6. Hydroethidine staining
Hydroethidine is one of the best reagents currently available for
measuring the intracellular concentration of the superoxide anion
(O2) [47,48]. The superoxide anion reacts with hydroethidine to pro-
duce ethidium bromide, which binds to nuclear DNA and emits ﬂuo-
rescence. Cells were washed brieﬂy with PBS, incubated with 5 lM
hydroethidine for 30 min, and then washed with PBS to remove any
excess dye prior to imaging. Fluorescence was detected using a laser
scanning confocal microscope operated at excitation and emission
wavelengths of 488 and 610 nm, respectively, and using a 585-nm
long-pass ﬁlter. The optical density of the ethidium ion was normalized
to the number of THP-1 cells and is expressed as the percentage max-
imal intensity of ox-LDL-derived foam cells.
2.7. Enzyme-linked immunosorbent assay (ELISA)
The secretion of IL1b protein upon stimulation of modiﬁed LDL
was characterized by ELISA using anti-IL1b IgG. Culture media were
measured for IL1b protein content. The acquired reading in optical
absorbance unit was normalized by the maximum signal.
2.8. Statistical analysis
All data from RT2PCR, ELISA, and hydroethidine staining are pre-
sented as means ± standard error of the mean (S.E.M.). Data sets were
evaluated using one-way analysis of variance (ANOVA). The mini-
mum level of signiﬁcance was set at P < 0.05.3. Results and discussion
To obtain large-scale gene expression patterns for lipid
loaded macrophages, we conducted microarray experiments
using cDNA microarray containing 9600 genes of sequence-
veriﬁed human cDNA. We performed time-course experiments
on both ac-LDL-laden foam cells (AFC) and copper-oxidized-
LDL-laden foam cells (OFC) while using untreated THP-1 cell
lines as the normal control. We harvested the cells 12, 24, 36,
48, and 72 h in duplicates after administration of the modiﬁed
LDL. Total RNA was ﬂuorescence-labeled and hybridized to
the microarray; we then detected the intensities using a laser-
excited scanner. After background subtraction, we performed
non-linear normalization using lowess procedure [44]. We de-
rived the ﬁnal expression ratios by comparing the results to
those of the untreated cell line; we transformed and the ratios
to the log2 scale for further data processing.
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gene clusters speciﬁc for AFC or OFC (Fig. 1). All microarray
datasets were clustered based on the variation of expression ra-
tios of 9600 genes. Genes were clustered based on similarity in
their expression patterns among diﬀerent time points. AFC and
OFC appealed as two distinct entities in the dendrogram, indi-
cating that AFC and OFC can be separated by the transcrip-
tional pattern. Commonly up or downregulated gene clustersFig. 1. Comparison of acetylated-LDL-loaded foam cells and oxi-
dized-LDL-loaded foam cells using the gene expression ratios derived
from the cDNA microarray. The diagram illustrates the results of
hierarchical cluster analysis, which were visualized using Treeview
software. Modiﬁed LDL was added to THP-1 cells, which were
harvested after 12, 24, 36, 48, and 72 h. The foam cells are clustered
based on the variation of the expression ratios of diﬀerentially
expressed genes, which are themselves based on the criteria described
in the text. Genes are clustered based on the similarities in their
expression patterns among foam cells. Each column represents a
speciﬁc treatment and each row a single gene. The colors, which reﬂect
the ratios on the log2-based scale, are depicted in the scale bar at the
bottom of the scheme. Green and red colors reﬂect lower- and higher-
than-control levels of gene expression, respectively. The gene clusters
that specify AFC-speciﬁc expression are highlighted with colored bars
(blue, gene cluster A; red, gene cluster B).were in greater proportion and spotted instantly. Judging from
the similar trends for the up and downregulated genes in both
entities, the diﬀerence in the expression pattern was minimal.
We could, however, identify two gene clusters that displayed
distinct expression patterns (Fig. 1, gene clusters A and B).
Oxidized LDL utilizes a wide spectrum of scavenger recep-
tors to enter macrophages; ac-LDL shares limited receptors
encoded by SR-AI/II. In addition, the chemical modiﬁcation
of ac-LDL is non-oxidative. Thus the striking similarity in
expression proﬁles between AFC and OFC implied that lipid
deposition might contribute in major part the pathogenic tran-
sition from macrophages to foam cells. However, functional
annotation to gene clusters common or unique to each type
of foam cells might provide further insights to the molecular
mechanisms that lead to atherogenesis.
3.1. Diﬀerentially expressed genes common to ac-LDL- and
ox-LDL-laden foam cells
Based on a previous report, a signiﬁcant molecular response
can be observed before our ﬁrst harvest time point [28]. For the
purpose of obtaining diﬀerentially expressed genes, the individ-
ual time points in the time course experiments should be trea-
ted equally. In the current study, we applied two methods to
identify the genes diﬀerentially expressed in AFC and OFC:
the SAM method to select the overall diﬀerentially expressed
genes [45] and the standard deviation (S.D.) to provide the
threshold. The multiplicity of P-values due to the consequence
of performing statistical tests on many genes in parallel was re-
solved by SAM method. We applied the SAM analysis to iden-
tify 323 upregulated genes and 124 downregulated genes from
the overall datasets; the values of the median number of false
positives, the false discovery rate, and delta were 0.56%, 0.13%,
and 0.897%, respectively. As a screening ﬁlter we also applied
the standard deviation of the microarray datasets of both the
AFC and OFC samples; candidate genes having folds higher
or lower than twice the SD were selected. We identiﬁed 315
upregulated genes and 165 downregulated genes for AFC
and 255 upregulated genes and 176 downregulated genes for
OFC. Eighty of the upregulated genes and 48 of the downreg-
ulated genes (Table 1) satisﬁed all of the criteria (SAM, SD of
AFC, and SD of OFC). The original microarray datasets – dif-
ferentially expressed genes identiﬁed by SAM and by SD-ﬁlter-
ing – have been posted on our website as supplementary
material (140.113.133.133/download/foam cells; Tables 1–4,
Supplementary Material).
The diﬀerentially expressed genes shared by both AFC and
OFC exhibited abnormality in apoptosis, extracellular matrix,
oxidative stress, and cell proliferation. A group of genes typical
for cell death and proliferation was spotted. Of most interest
are interleukin 1 beta (IL1b), v-akt murine thymoma viral
oncogene homolog 1, epithelial membrane protein 1, epithelial
membrane protein 3, sterile alpha motif and leucine zipper
containing kinase AZK, cell division cycle 2, and cell division
cycle 23. IL1b, which is an important mediator of the inﬂam-
matory response, is involved in a variety of cellular activities,
including cell proliferation, diﬀerentiation, and apoptosis.
IL1b polymorphism is the risk factor of myocardial infarction
and ischemic stroke at a young age [49]. The upregulation of
IL1b strongly suggests the induction of inﬂammatory response
by internalized lipids.
AKT1 encodes a serine/threonine protein kinase. In the
developing nervous system, AKT is a critical mediator of
Table 1
Commonly up or downregulated genes in foam cells
LLIDa Name Symbol AFCb OFC FC P-valuec Pathwayd
207 v-akt murine thymoma viral oncogene homolog 1 AKT1 0.52 0.53 0.52 0.00173 Regulation of cell cycle
208 v-akt murine thymoma viral oncogene homolog 2 AKT2 0.55 0.5 0.53 0 Regulation of cell cycle
229 Aldolase B, fructose-bisphosphate ALDOB 0.53 0.55 0.54 0 Glycolysis
239 Arachidonate 12-lipoxygenase ALOX12 0.42 0.47 0.44 0 Leukotriene biosynthesis
323 Amyloid beta (A4) precursor protein-binding, family B,
member 2 (Fe65-like)
APBB2 2.6 1.8 2.3 0.00046 Cell cycle arrest
372 Archain 1 ARCN1 1.9 1.9 1.9 0.00006 Intracellular protein
transport
720 Complement component 4A C4A 0.5 0.41 0.46 0.00013 Inﬂammatory response
760 Ccarbonic anhydrase II CA2 0.25 0.28 0.26 0 One-carbon compound
metabolism
781 Calcium channel, voltage-dependent, alpha 2/delta subunit
1
CACNA2D1 3.1 2.4 2.8 0.00015 Ion transport
948 CD36 antigen (collagen type I receptor, thrombospondin
receptor)
CD36 2.8 2.5 2.6 0 Fatty acid metabolism
983 Cell division cycle 2, G1 to S and G2 to M CDC2 0.41 0.42 0.41 0.00098 Mitosis
987 LPS-responsive vesicle traﬃcking, beach and anchor
containing
LRBA 6.6 3.9 5.3 0.00003
1009 Cadherin 11, type 2, OB-cadherin (osteoblast) CDH11 2 2.1 2 0.00013 Homophilic cell adhesion
1511 Cathepsin G CTSG 0.39 0.39 0.39 0 Immune response
1511 Cathepsin G CTSG 0.4 0.34 0.37 0.00028 Immune response
1519 Cathepsin O CTSO 2.6 2.3 2.5 0 Proteolysis and peptidolysis
1535 Cytochrome b-245, alpha polypeptide CYBA 0.42 0.39 0.41 0.00004 Superoxide metabolism
1536 Cytochrome b-245, beta polypeptide (chronic
granulomatous disease)
CYBB 0.38 0.54 0.43 0.00005 Inﬂammatory response
1536 Cytochrome b-245, beta polypeptide (chronic
granulomatous disease)
CYBB 0.37 0.54 0.43 0.00255 Inﬂammatory response
1565 Cytochrome P450, subfamily IID (debrisoquine, sparteine,
etc., -metabolising), polypeptide 7a (pseudogene)
CYP2D7AP 2.6 2 2.3 0.00022 Electron transport
1741 Discs, large homolog 3 (neuroendocrine-dlg, Drosophila) DLG3 2.6 2.2 2.5 0 Negative regulation of cell
proliferation
1827 Down syndrome critical region gene 1 DSCR1 2.9 2.4 2.7 0.00005 Calcium-mediated signaling
1841 Deoxythymidylate kinase (thymidylate kinase) DTYMK 0.51 0.45 0.48 0 DNA metabolism
1854 dUTP pyrophosphatase DUT 0.45 0.46 0.45 0.00255 DNA replication
1893 Extracellular matrix protein 1 ECM1 0.54 0.44 0.5 0.00001 Transport
2012 Epithelial membrane protein 1 EMP1 3.2 3.7 3.4 0 Epidermal diﬀerentiation
2014 Epithelial membrane protein 3 EMP3 0.45 0.42 0.44 0.00001 Ccell growth
2335 Fibronectin 1 FN1 0.48 0.41 0.45 0.00093 Cell adhesion
3151 High-mobility group nucleosomal binding domain 2 HMGN2 2.4 2.4 2.4 0 Establishment and/or
maintenance of
chromatin architecture
3176 Histamine N-methyltransferase HNMT 2.1 2.1 2.1 0 Respiratory gaseous exchange
3192 Heterogeneous nuclear ribonucleoprotein U (scaﬀold
attachment factor A)
HNRPU 2.1 1.9 2 0.00011 RNA processing
3251 Hypoxanthine phosphoribosyltransferase 1 (Lesch-Nyhan
syndrome)
HPRT1 2.5 2.4 2.5 0 Nucleoside metabolism
3553 Interleukin 1, beta IL1b 2.2 2.3 2.2 0.00037 Inﬂammatory response
3566 Interleukin 4 receptor IL4R 0.3 0.5 0.37 0.00209 Immune response
3601 Interleukin 15 receptor, alpha IL15RA 0.53 0.53 0.53 0.00013 Cell proliferation
3866 Keratin 15 KRT15 2 1.8 1.9 0.00412 Epidermal diﬀerentiation
3934 Lipocalin 2 (oncogene 24p3) LCN2 1.9 1.9 1.9 0.00002 Transport
4001 Lamin B1 LMNB1 0.48 0.41 0.45 0.00099
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4015 Lysyl oxidase LOX 2.3 1.8 2.1 0.0004 Protein modiﬁcation
4179 Membrane cofactor protein (CD46, trophoblast–
lymphocyte cross-reactive antigen)
MCP 0.43 0.37 0.41 0 Invasive growth
4330 Meningioma (disrupted in balanced translocation) 1 MN1 2.7 1.8 2.3 0.000 1 Negative regulation of cell cycle
4332 Myeloid cell nuclear diﬀerentiation antigen MNDA 0.48 0.45 0.47 0.000 4 Cellular defense response
4332 Myeloid cell nuclear diﬀerentiation antigen MNDA 0.46 0.46 0.46 0.000 3 Cellular defense response
4485 Macrophage stimulating 1 (hepatocyte growth factor-like) MST1 4.1 2.2 3.2 0.000 9 Proteolysis and peptidolysis
4613 v-myc myelocytomatosis viral related oncogene,
neuroblastoma derived (avian)
MYCN 1.8 2.5 2.1 0.000 3 Cell growth and/or maintenance
4649 Myosin IXA MYO9A 2 2.3 2.1 0 Intracellular signaling cascade
4726 NADH dehydrogenase (ubiquinone) Fe–S protein 6,
13 kDa (NADH-coenzyme Q reductase)
NDUFS6 3.1 3.6 3.3 0 Mitochondrial electron transport,
NADH to ubiquinone
4807 Nescient helix–loop–helix 1 NHLH1 3.1 2.6 2.9 0.000 3 Cell diﬀerentiation
4907 5 0-nucleotidase, ecto (CD73) NT5E 3.8 4.6 4.1 0 DNA metabolism
4907 5 0-nucleotidase, ecto (CD73) NT5E 3.1 3.6 3.3 0.000 5 DNA metabolism
5007 Oxysterol binding protein OSBP 1.9 1.9 1.9 0.002 2 Steroid metabolism
5125 Proprotein convertase subtilisin/kexin type 5 PCSK5 0.59 0.48 0.54 0.000 4 Proteolysis and peptidolysis
5126 Proprotein convertase subtilisin/kexin type 2 PCSK2 2.2 2.4 2.3 0 Proteolysis and peptidolysis
5216 Proﬁlin 1 PFN1 0.39 0.48 0.43 0.003 3 Actin cytoskeleton organization
and biogenesis
5229 Protein geranylgeranyltransferase type I, beta subunit PGGT1B 1.8 2.3 2 0.000 3 Protein amino acid geranylgeranylation
5230 Phosphoglycerate kinase 1 PGK1 2.7 1.9 2.3 0.000 2 Glycolysis
5319 Phospholipase A2, group IB (pancreas) PLA2G1B 1.9 1.8 1.9 0.000 6 Lipid catabolism
5441 Polymerase (RNA) II (DNA directed) polypeptide L,
7.6 kDa
POLR2L 2.4 1.9 2.2 0.000 2 Regulation of transcription from
Pol I promoter
5465 Peroxisome proliferative activated receptor, alpha PPARA 4.1 3.5 3.8 0 Regulation of fatty acid metabolism
5465 Peroxisome proliferative activated receptor, alpha PPARA 2.6 2.6 2.6 0.000 5 Regulation of fatty acid metabolism
5468 Peroxisome proliferative activated receptor, gamma PPARG 5.1 2.9 4.1 0 Lipid metabolism
5636 Phosphoribosyl pyrophosphate synthetase-associated
protein 2
PRPSAP2 0.46 0.5 0.48 0.002 4 Nucleoside metabolism
5699 Proteasome (prosome, macropain) subunit, beta type, 10 PSMB10 0.51 0.52 0.52 0.000 9 Humoral immune response
5770 Protein tyrosine phosphatase, non-receptor type 1 PTPN1 1.8 2.1 1.9 0.000 2 Protein amino acid dephosphorylation
5781 Protein tyrosine phosphatase, non-receptor type 11
(Noonan syndrome 1)
PTPN11 2.8 2 2.5 0.000 Protein amino acid dephosphorylation
5792 Protein tyrosine phosphatase, receptor type, F PTPRF 2.1 2 2.1 0.000 6 Cell adhesion
5816 Parvalbumin PVALB 1.8 1.9 1.8 0.000 4 Muscle development
5836 Phosphorylase, glycogen; liver (Hers disease, glycogen
storage disease type VI)
PYGL 0.6 0.45 0.53 0.000 1 Glycogen metabolism
5911 RAP2A, member of RAS oncogene family RAP2A 1.8 2.2 2 0.000 9 Small GTPase mediated signal transduction
5919 Retinoic acid receptor responder (tazarotene induced) 2 RARRES2 0.52 0.52 0.52 0.000 6 Retinoid metabolism
6036 Ribonuclease, RNase A family, 2 (liver, eosinophil-derived
neurotoxin)
RNASE2 0.42 0.37 0.4 0 Chemotaxis
6182 Mitochondrial ribosomal protein L12 MRPL12 2.2 1.9 2 0.001 8 Protein biosynthesis
6302 Sarcoma ampliﬁed sequence SAS 0.51 0.54 0.52 0.000 6 Positive regulation of cell proliferation
6392 Succinate dehydrogenase complex, subunit D, integral
membrane protein
SDHD 3 2.6 2.8 0.000 2 Electron transport
6418 SET translocation (myeloid leukemia-associated) SET 2.1 1.9 2 0.000 Oncogenesis
6444 Sarcoglycan, delta (35 kDa dystrophin-associated
glycoprotein)
SGCD 0.53 0.47 0.51 0.001 9 Muscle development
6710 Spectrin, beta, erythrocytic (includes spherocytosis,
clinical type I)
SPTB 0.63 0.26 0.44 0.000 5
6745 Signal sequence receptor, alpha (translocon-associated
protein alpha)
SSR1 0.53 0.42 0.48 0 Positive regulation of cell proliferation
(continued on next page)
Y
.-C
.
H
u
n
g
et
a
l.
/
F
E
B
S
L
etters
5
8
0
(
2
0
0
6
)
8
4
9
–
8
6
1
8
5
38
0
0
0
0
0
0
5
2
2
1
0
0
2
0
0
2
4
8
2
0
1
0
0
1
0
0
1
7
3
Table 1 (continued)
LLIDa Name Symbol AFCb OFC FC P-valuec Pathwayd
7021 Transcription factor AP-2 beta (activating enhancer
binding protein 2 beta)
TFAP2B 2.7 2 2.4 0.0001 Regulation of transcription from
Pol II promoter
7056 Thrombomodulin THBD 2.5 3.1 2.7 0.00008 Blood coagulation
7057 Thrombospondin 1 THBS1 0.34 0.44 0.38 0.00001 Cell adhesion
7289 Tubby like protein 3 TULP3 2 1.8 1.9 0.00421 G-protein coupled receptor protein
signaling pathway
7298 Thymidylate synthetase TYMS 0.41 0.48 0.43 0 dTMP biosynthesis
7298 Thymidylate synthetase TYMS 0.37 0.55 0.43 0.00002 dTMP biosynthesis
7337 Ubiquitin protein ligase E3A (human papilloma virus E6-
associated protein, Angelman syndrome)
UBE3A 2.8 1.9 2.4 0.00052 Ubiquitin-dependent protein catabolism
7378 Uridine phosphorylase 1 UPP1 1.8 2.2 1.9 0.00115 Nucleoside metabolism
8204 Nuclear receptor interacting protein 1 NRIP1 2.1 1.8 2 0.00005 Regulation of transcription,
DNA-dependent
8519 Interferon induced transmembrane protein 1 (9–27) IFITM1 0.34 0.46 0.38 0.00003 Immune response
8697 CDC23 (cell division cycle 23, yeast, homolog) CDC23 0.49 0.34 0.42 0.00201 Cytokinesis
8906 Adaptor-related protein complex 1, gamma 2 subunit AP1G2 2.8 2.4 2.6 0.00001 Intracellular protein transport
9145 Synaptogyrin 1 SYNGR1 4.1 2.7 3.5 0.00003 Transport
9314 Kruppel-like factor 4 (gut) KLF4 0.5 0.52 0.51 0.00147 Negative regulation of cell proliferation
9486 Carbohydrate sulfotransferase 10 CHST10 1.9 2.3 2 0.00096 Cell adhesion
9653 Heparan sulfate 2-O-sulfotransferase 1 HS2ST1 0.54 0.52 0.53 0.00006 Protein amino acid sulfation
9820 Cullin 7 CUL7 1.8 1.9 1.8 0.00076
9969 Thyroid hormone receptor associated protein 1 THRAP1 1.8 2.2 2 0 Androgen receptor signaling pathway
10121 ARP1 actin-related protein 1 homolog A, centractin alpha
(yeast)
ACTR1A 0.51 0.48 0.49 0.00074 Vesicle-mediated transport
10215 Oligodendrocyte lineage transcription factor 2 OLIG2 2.4 2.6 2.5 0 Cell growth and/or maintenance
10216 Proteoglycan 4, (megakaryocyte stimulating factor,
articular superﬁcial zone protein, camptodactyly,
arthropathy, coxa vara, pericarditis syndrome)
PRG4 0.33 0.5 0.39 0.00089 Cell proliferation
10262 Splicing factor 3b, subunit 4, 49 kDa SF3B4 7.3 4 5.7 0.00016 Nuclear mRNA splicing, via spliceosome
10959 Coated vesicle membrane protein RNP24 2.3 2 2.1 0.00083 Intracellular protein transport
10969 EBNA1 binding protein 2 EBNA1BP2 3.1 2.7 3 0 G-protein coupled receptor protein
signaling
pathway
10981 RAB32, member RAS oncogene family RAB32 0.47 0.5 0.48 0.00008 Protein transport
11273 ataxin 2 related protein A2LP 3.2 3.5 3.3 0
11344 PTK9L protein tyrosine kinase 9-like (A6-related protein) PTK9L 1.7 2.3 1.9 0.00069 Intracellular signaling cascade
22795 Nidogen 2 (osteonidogen) NID2 2 2.1 2 0.00001 Cell–matrix adhesion
23203 Peptidase (mitochondrial processing) alpha PMPCA 3.7 3.3 3.5 0 Proteolysis and peptidolysis
23209 Megalencephalic leukoencephalopathy with subcortical
cysts 1
MLC1 3.1 2 2.6 0.0002 Transport
23358 Ubiquitin speciﬁc protease 24 USP24 2 1.8 1.9 0 Ubiquitin-dependent protein catabolism
25911 Deleted in a mouse model of primary ciliary dyskinesia DPCD 2.8 2.1 2.5 0.00003
26275 3-Hydroxyisobutyryl-coenzyme A hydrolase HIBCH 2.4 1.8 2.2 0.00002 Metabolism
27316 RNA binding motif protein, X-linked RBMX 2.4 2.3 2.4 0.00328 Regulation of transcription,
DNA-dependent
29974 apobec-1 complementation factor ACF 3.5 2.3 2.9 0 mRNA editing
50486 Putative lymphocyte G0/G1 switch gene G0S2 0.47 0.43 0.45 0.00025 Regulation of cell cycle
51776 Sterile alpha motif and leucine zipper containing kinase
AZK
ZAK 0.57 0.57 0.57 0.00018 Cell death
55336 Heat shock transcription factor 4 HSF4 0.52 0.53 0.53 0.00007
55567 Dynein, axonemal, heavy polypeptide 3 DNAH3 2.7 2.1 2.4 0.00015 Microtubule-based movement
64714 Protein disulﬁde isomerase PDI 2.2 1.9 2.1 0.00017 Electron transport
80204 F-box protein 11 FBXO11 2.1 2.2 2.1 0 Ubiquitin-dependent protein catabolism
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Y.-C. Hung et al. / FEBS Letters 580 (2006) 849–861 855growth factor-induced neuronal survival. Survival factors can
suppress apoptosis in a transcription-independent manner by
activating this serine/threonine kinase, which then phosphory-
lates and inactivates components of the apoptotic machinery.
Immunostaining and microarray evidence suggests that
AKT1 is downregulated at recurrent carotid stenosis [50].
The downregulation of AKT1 suggests activation of apoptotic
machinery and is consistent with the observation that both
AFC and OFC underwent apoptosis.
Extracellular matrix remodeling of foam cells has been sug-
gested to occur through the downregulation of ﬁbronectin and
spectrin. Spectrin is the major constituent protein of the eryth-
rocyte cytoskeleton that forms a ﬁlamentous network on the
cytoplasmic face of the membrane. The major function of spec-
trin is presumed to be that of establishing the cytoskeletal net-
work that provides mechanical strength to the cell membrane.
The diﬀerential expression for oxidative stress is indicated by
arachidonate 12-lipoxygenase, cytochrome b-245 alpha and
beta, cytochrome P450 2D6, lysyl oxidase, NADH dehydroge-
nase, protein disulﬁde isomerase, and egl nine homolog 2. Of
particular interest is EGL nine homolog 2 [EGLN2 or hypox-
ia-inducible factor (HIF)], a transcriptional regulator that
plays a key role in hypoxia [51]. Over-expression of ENGLN2
has been identiﬁed in the myocardial microvessels and coro-
nary artery of a hypercholesterolimic pig [52]. Further studies
into the role of EGLN2 during atherogenesis should prove
insightful. The upregulation of LPS-responsive vesicle traﬃck-
ing (LRBA) indicated that the delicate balance of intracellular
cholesterol traﬃcking was severely disturbed [53,54]. The
upregulation of 5 0-nucleotidase, ecto (CD73), is consistent with
the elevation of enzyme activity for CD73 in the human ath-
erosclerotic aorta [55,56]. Additionally, the over-expression
of peroxisome proliferative activated receptors (PPARA,
PPARD), thrombomodulin (THBD), CD36, and interleukin
1 beta (IL1b) are consistent with the results of a previous re-
port [57–61]. In particular, signiﬁcant over-expression of cyto-
chrome P450 and acyl-Coenzyme A dehydrogenase indicate
the increase in oxidative stress in both AFC and OFC.3.2. Genes that distinguish AFC and OFC
To identify gene clusters that distinguish AFC from OFC,
we started with the gene clusters A and B from Fig. 1 and over-
lapped with diﬀerentially expressed genes that are statistically
signiﬁcant from microarray datasets. We obtained 87 AFC-
speciﬁc genes (Table 2) and 31 OFC-speciﬁc genes (Table 3).
AFC-speciﬁc genes exhibited changes in the metabolic path-
ways including kinase activity, ATP binding activity, and trans-
porter activity. Fifteen genes are categorized as kinase activity
including. Of most interest are PCTAIRE protein kinases 1
and 3. These genes belong to the cdc2/cdkx subfamily of the
ser/thr family of protein kinases. They may play a role in signal
transduction cascades in terminally diﬀerentiated cells. Eight
genes are involved in transporter activity. There are a few chan-
nel proteins including chloride channels (CLCN6, CLIC2,
SLC12A4), potassium channels (KCNF1, KCNJ4, SLC12A4),
proteins associated with mitochondria ion transport (FRDA,
UCP3), and peroxisome-associated enzyme (DDO).
OFC-speciﬁc genes exhibited completely diﬀerent functions
in cell signaling and adhesion. The protein encoded by JAG2
activates Notch and related receptors. The Notch signaling
pathway is an intercellular signaling mechanism that is
Table 2
Genes speciﬁcally up or downregulated in AFC
LLID Symbol AFCa OFC FC OFC/AFC P-valueb Pathwayc
156 ADRBK1 1.95 0.98 1.48 0.5 0.00155 Signal transduction
229 ALDOB 0.52 0.86 0.64 1.64 0.01333 Glycolysis
808 CALM3 2.09 1.22 1.68 0.58 0.00564
1121 CHM 3.09 1.55 2.34 0.5 0.00073 Non-selective vesicle transport
1185 CLCN6 1.93 1.08 1.53 0.56 0.00135 Chloride transport
1193 CLIC2 2.88 1.28 2.09 0.45 0.00021 Chloride transport
1361 CPB2 0.53 1.04 0.69 1.97 0.00034 Proteolysis and peptidolysis
1611 DAP 2.09 1.14 1.64 0.54 0.00103 Induction of apoptosis by extracellular signals
1659 DHX8 2.43 1.1 1.77 0.45 0.00205 Nuclear mRNA splicing, via spliceosome
1760 DMPK 2.37 1.43 1.94 0.6 0.00396 Protein amino acid phosphorylation
2098 ESD 1.9 1.06 1.51 0.56 0.0002
2140 EYA3 2.47 1.3 1.91 0.53 0.00085 Morphogenesis
2261 FGFR3 2.43 0.97 1.69 0.4 0.00388 MAPKKK cascade
2275 FHL3 2.51 1.31 1.94 0.52 0.00561 Muscle development
2335 FN1 2.56 1.42 2.03 0.56 0.00123 Cell adhesion
2395 FRDA 2.03 1.06 1.57 0.52 0.00067 Vesicle-mediated transport
2553 GABPB1 2.07 1.14 1.63 0.55 0.0001 Regulation of transcription from Pol II promoter
2589 GALNT1 2.4 1.41 1.94 0.59 0.01466 Heterophilic cell adhesion
2592 GALT 2.64 1.29 1.98 0.49 0.01065 Galactose metabolism
2687 GGTLA1 1.81 0.96 1.4 0.53 0.00318 Glutathione biosynthesis
2737 GLI3 2.18 1.02 1.61 0.47 0.00496 Morphogenesis
2739 GLO1 0.49 0.85 0.61 1.75 0.00118 Carbohydrate metabolism
2899 GRIK3 2.48 1.06 1.76 0.43 0.01348 Glutamate signaling pathway
2932 GSK3B 2.43 1.23 1.85 0.5 0.01081 Anti-apoptosis
2939 GSTA2 2.29 1.18 1.76 0.51 0.01667 Glutathione conjugation reaction
3276 HRMT1L2 2.08 1.02 1.56 0.49 0.00061 Protein amino acid methylation
3754 KCNF1 2.16 1.11 1.66 0.51 0.00453 Potassium ion transport
3761 KCNJ4 0.33 0.73 0.45 2.2 0.01765 Potassium ion transport
3953 HSOBRGRP 1.8 1.08 1.47 0.6 0.00176 Cell surface receptor linked signal transduction
4034 LRCH4 0.44 0.77 0.55 1.74 0.00172 Neurogenesis
4043 LRPAP1 1.71 0.78 1.25 0.46 0.00297 Vesicle-mediated transport
4052 LTBP1 2.46 0.94 1.68 0.38 0.00625
4324 MMP15 2.22 0.88 1.53 0.39 0.00051 Proteolysis and peptidolysis
4363 ABCC1 1.92 1.06 1.51 0.55 0.00422 Protein amino acid phosphorylation
4486 MST1R 2.75 1.35 2.07 0.49 0.00018 Protein amino acid phosphorylation
4515 MTCP1 2.14 1.03 1.6 0.48 0.01469 Regulation of cell cycle
5076 PAX2 0.4 0.88 0.55 2.17 0.00597 Cell diﬀerentiation
5127 PCTK1 2.32 1.39 1.89 0.6 0.02153 Protein amino acid phosphorylation
5129 PCTK3 2.11 1.21 1.69 0.57 0.00001 Protein amino acid phosphorylation
5272 SERPINB9 2.82 1.46 2.17 0.52 0.00671
5351 PLOD 2.23 0.72 1.42 0.32 0.00145 Epidermal diﬀerentiation
5393 EXOSC9 2.22 1.11 1.68 0.5 0.00406 Immune response
5583 PRKCH 2.24 1.37 1.84 0.61 0.00005 Protein amino acid phosphorylation
5790 PTPRCAP 2.16 1.19 1.71 0.55 0.00084
5983 RFC3 2.43 1.48 1.99 0.61 0.00114 DNA strand elongation
6259 RYK 1.95 1.15 1.58 0.59 0.00124 Protein amino acid phosphorylation
6370 CCL25 2.9 1.52 2.24 0.53 0.00356 Inﬂammatory response
6560 SLC12A4 2.05 1.19 1.65 0.58 0.0002 Potassium ion transport
6573 SLC19A1 1.85 0.92 1.4 0.5 0.00259 Folate transport
6645 SNTB2 2.23 1.14 1.7 0.51 0.0051
6654 SOS1 0.56 1.68 0.87 3 0.00425 RAS protein signal transduction
6789 STK4 1.7 0.91 1.32 0.53 0.00035 Protein amino acid phosphorylation
6881 TAF10 2.22 1.13 1.69 0.51 0.00005 Transport
6947 TCN1 2.32 0.84 1.54 0.36 0.00681 Vitamin B12 transport
7059 THBS3 1.93 1.13 1.55 0.58 0.01054 Cell–matrix adhesion
7153 TOP2A 0.54 0.92 0.67 1.71 0.0062 DNA topological change
7287 TULP1 0.38 0.99 0.56 2.57 0.01052 Vision
7352 UCP3 2.29 1.38 1.87 0.6 0.01524 Lipid metabolism
7803 PTP4A1 2.65 1.39 2.05 0.52 0.00546 Protein amino acid dephosphorylation
8021 NUP214 2.14 1.03 1.6 0.48 0.00307 Oncogenesis
8091 HMGA2 2.3 0.79 1.5 0.34 0.0019 Development
8528 DDO 0.52 0.93 0.66 1.77 0.00003 Electron transport
8663 EIF3S8 1.88 1.12 1.53 0.59 0.0122 Regulation of translational initiation
9061 PAPSS1 2.15 0.8 1.45 0.37 0.00252 Sulfate assimilation
9094 UNC119 2.17 1.18 1.7 0.54 0.0032 Synaptic transmission
9334 B4GALT5 0.55 1.12 0.73 2.03 0.01625 Sphingolipid biosynthesis
9462 RASAL2 2.61 0.92 1.72 0.35 0.0009 Signal transduction
9540 TP53I3 0.49 1.04 0.66 2.1 0.01713
10146 G3BP 2.55 1.27 1.93 0.5 0.00037 RAS protein signal transduction
10899 JTB 2.14 1.08 1.63 0.51 0.002 Oncogenesis
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Table 2 (continued)
LLID Symbol AFCa OFC FC OFC/AFC P-valueb Pathwayc
10914 PAPOLA 2.45 1.17 1.82 0.48 0.00489
23016 EXOSC7 2.21 1.05 1.64 0.48 0.00132 RNA catabolism
23034 SAMD4 2.08 0.91 1.49 0.44 0.00819
23301 NACSIN 0.56 0.93 0.69 1.68 0.01276 Ubiquitin cycle
23509 POFUT1 0.42 0.86 0.56 2.06 0.00141 N-signaling pathway
23518 R3HDM 0.56 1.19 0.75 2.14 0.00401
23769 FLRT1 1.92 1.04 1.51 0.54 0.00229 Lipid catabolism
27254 PIPPIN 0.56 0.93 0.68 1.67 0.0011 mRNA processing
27347 STK39 2.81 1.56 2.22 0.56 0.00507 Protein amino acid phosphorylation
55168 MRPS18A 3.6 1.5 2.53 0.42 0.00109 Protein biosynthesis
55544 RNPC1 3.02 1.04 1.97 0.35 0.00274
56928 SPPL2B 0.5 0.82 0.61 1.64 0.01513 Proteolysis and peptidolysis
58525 WIZ 2.78 1.2 1.98 0.43 0.00524 Regulation of transcription, DNA-dependent
80347 COASY 2.45 1.25 1.87 0.51 0.00591 Coenzyme A biosynthesis
84958 SYTL1 0.46 0.87 0.59 1.91 0.00932 Transport
85006 PDXK 2.18 1.18 1.71 0.54 0.00869
124583 ENTPD8 1.87 1.13 1.53 0.6 0.00409
aValues represent averaged fold change for all time course experiments. AFC, ac-LDL-loaded foam cells; OFC, ox-LDL-laden foam cells; FC, mean
value of AFC and OFC. OFC/AFC depicts expression ratio of OFC compared to AFC.
bP-values are results from t-test for all fold changes of AFC.
cPathway is derived from GO-biological process. The plain text depicts representative pathway among several possible pathways. The bold text
depicts unique pathway. The complete table is available on our website.
Y.-C. Hung et al. / FEBS Letters 580 (2006) 849–861 857essential for proper embryonic development and various cell
fate decisions. Adhesion molecules such as collagen
(COL4A5), chemokine (C–C motif) ligand 2, and desmocollin
2 (DSC2) were unique for OFC. It is intriguing that AFC and
OFC expressed diﬀerently in functions which are not directlyTable 3
Genes speciﬁcally up or downregulated in OFC
LLID Symbol AFC OFC FC OFC/AFC P-
10388 SYCP2 1.45 3.58 2.08 2.46 0.0
4141 MARS 1.5 3.04 1.99 2.03 0.0
1824 DSC2 1.13 2.83 1.63 2.51 0.0
51626 D2LIC 1.24 2.35 1.6 1.9 0.0
7221 TRPC2 1.14 2.26 1.5 1.99 0.0
80852 GRIP2 1.27 2.26 1.6 1.78 0.0
1287 COL4A5 1.34 2.25 1.65 1.67 0.0
2796 GNRH1 1.14 2.19 1.48 1.92 0.0
4295 MLN 1.07 2.16 1.42 2.01 0.0
150160 CESK1 1.31 2.16 1.6 1.64 0.0
94056 SYAP1 1.23 2.15 1.53 1.75 0.0
10420 TESK2 1.21 2.1 1.51 1.74 0.0
945 CD33 1.16 1.96 1.44 1.69 0.0
3714 JAG2 0.8 1.93 1.14 2.41 0.0
1258 CNGB1 0.92 0.55 0.75 0.6 0.0
53358 SHC3 0.98 0.55 0.78 0.57 0.0
64116 SLC39A8 0.91 0.55 0.75 0.61 0.0
23305 KIAA0837 1.02 0.53 0.78 0.51 0.0
3235 HOXD9 0.91 0.52 0.72 0.57 0.0
4131 MAP1B 0.97 0.52 0.76 0.54 0.0
7355 SLC35A2 0.82 0.5 0.67 0.61 0.0
7386 UQCRFS1 0.8 0.49 0.66 0.61 0.0
2731 GLDC 1.04 0.46 0.75 0.44 0.0
2950 GSTP1 0.9 0.46 0.68 0.51 0.0
5360 PLTP 0.88 0.46 0.68 0.53 0.0
55644 OSGEP 1.12 0.43 0.77 0.39 0.0
3117 HLA-DQA1 0.66 0.4 0.54 0.6 0.0
1973 EIF4A1 1.3 0.39 0.81 0.3 0.0
6347 CCL2 0.66 0.39 0.53 0.58 0.0
6628 SNRPB 0.61 0.37 0.5 0.61 0.0
6710 SPTB 0.63 0.26 0.44 0.41 0.0
aP-values depict results from t-test for all fold changes of OFC.
bPathway is derived from GO-biological process. The plain text depicts rep
depicts unique pathway. The complete table is available on our website.related to oxidative stress. The altered functions for AFC are
metabolic pathways while for OFC are cell–cell interaction.
It is worthy to mention that cluster analysis recognized
groups of genes with early response and late response. Early
response genes include several genes associated with peroxi-valuea Pathwayb
1835 Cytokinesis
1486 Methionyl-tRNA aminoacylation
2016 Homophilic cell adhesion
2581
4529
1233
0664 Cell adhesion
1273 Cell–cell signaling
0512 Cell–cell signaling
0123 Protein folding
0264
101 Apoptosis
2362 Cell–cell signaling
2716 Regulation of cell proliferation
5409 Potassium ion transport
316 Intracellular signaling cascade
2339 Metal ion transport
3268
0566 Regulation of transcription DNA-dependent
348
1838 Galactose metabolism
0346 Electron transport
1506 Glycine catabolism
3526 Metabolism
2491 Lipid metabolism
3314 Proteolysis and peptidolysis
1553 Antigen processing exogenous antigen via MHC class II
4056 Regulation of translational initiation
0543 Inﬂammatory response
0362 RNA splicing
0077
resentative pathway among several possible pathways. The bold text
858 Y.-C. Hung et al. / FEBS Letters 580 (2006) 849–861some (MVK, PXF, PXR1, and MLYCD) ande lyase activity
(GAD1, IREB2, ODC1, PAICS, and MLYCD). Late response
consist genes associated with glutathione biosynthesis
(GGTLA1, GCLC, GCLM), acyl-CoA (MYO9B, PRKCD,
PRKCG, PRKCH, KIAA0513), and more than 70 genes in
protein metabolism.
3.3. Genes associated with oxidative stress were insuﬃcient to
distinguish AFC from OFC
To explore the possibility that genes associated with oxida-
tive stress might be capable of distinguishing ac-LDL from
ox-LDL foam cells, we performed a cluster analysis after
selecting 95 genes listed in the category of oxidative stress
(Fig. 2; genes are listed in Table 5, Supplementary Material).
We observed no obvious pattern, suggesting that the expres-
sion pattern of genes associated with oxidative stress was insuf-
ﬁcient to distinguish AFC from OFC.
3.4. Validation of expression by real-time RT-PCR
To validate common or unique expression of genes in AFC
and OFC EGLN2, AKT1, PCTAIRE protein kinase 1
(PCTK1), and jagged 2 (JAG2) were selected for further anal-
ysis by real time RT-PCR (Fig. 3). ENGL2 is commonly
upregulated and AKT1 is commonly downregulated both in
AFC and OFC. PCTK1 is highly expressed in AFC and
JAG2 is highly expressed in OFC. The time course-dependent
expression in general agreed with microarray prediction.3.5. Induction of IL1b suggested increased oxidative stress in
cholesterol-loaded THP-1 cells
Interleukin 1 beta is a key enzyme for triggering cytokine re-
sponse in cells; it is also a well-studied marker for OFC. IL1b
was scored in the clusters that distinguished AFC from OFC.Fig. 2. Comparison of acetylated- and oxidized-LDL-loaded foam
cells using the oxidative stress-speciﬁc gene expression ratios selected
from the cDNA microarray.We hypothesized that IL1b would exhibit a diﬀerential expres-
sion pattern between these two types of foam cells. To validate
the transcriptional levels of interleukin 1 beta in the ac-LDL-
and ox-LDL laden foam cells, we performed real-time RT-
PCR of the total RNA extracted from macrophages adminis-
tered with modiﬁed LDL and harvested the samples at various
points of time (Fig. 4). The ox-LDL foam cells reached a high
level of IL1b expression after 12 h; they maintained that level
to the end. The internalization of ac-LDL by macrophages
brieﬂy induced a high level of IL1b expression after incubation
for 12 h, but the transcriptional level dropped rapidly (to be-
low fourfold after 24 h) and eventually returned to the normal
level at the end of the time course.
The secretion of IL1b protein was obtained by ELISA
(Fig. 5). IL1b was induced transiently in AFC while consis-
tently maintained in OFC. The similar induction pattern of
IL1b is consistent with the transcriptional results obtained
by real-time RT-PCR.3.6. Accumulation of superoxide in foam cells
Superoxide accumulation is a direct index of the oxidative
stress present in foam cells [62]. We stained the foam cells
with hydroethidine and then performed ﬂuorescence imaging
to quantify the ﬂuorescence within their nuclei [47,48]. Fig. 6
presents the results of our time course experiment. For all of
the foam cells, the ﬂuorescence intensity rose rapidly,
reached a plateau after 24 h, and then maintained a high le-
vel of intensity to the end. We noticed that the ﬂuorescence
levels of AFC dropped signiﬁcantly after 36 h, but recovered
and maintained a high level of ﬂuorescence after 48 h. These
hydroethidine staining experiments indicate that the steady
state levels of superoxide in AFC and OFC remained high
and that superoxide may contribute to the pathogenesis of
disease progression.3.7. Extracellular and intracellular oxidative modiﬁcation
Cholesterol loading induced high levels of steady state super-
oxide that were indistinguishable in both AFC and OFC. Our
results demonstrate that the internalization of cholesterol –
without oxidative modiﬁcation – by macrophages is suﬃcient
to trigger cellular reactions leading to the generation of super-
oxide. We have reported previously that, upon internalization,
ac-LDL generates the MDA-lysine epitope in foam cells [41]. It
is plausible to suggest that cholesterol loading induces super-
oxide production, lipid peroxidation, and subsequent genera-
tion of MDA-modiﬁcation to proteins. Lipid internalization,
whether oxidative or non-oxidative, is a potent factor that in-
creases the oxidative stress in macrophages.
Gene candidates that distinguish AFC from OFC may re-
veal the intricacies of these two entities. Functional annotation
indicated deregulation for hormone activity, which we vali-
dated through the diﬀerential expression of IL1b in AFC
and OFC. IL1b is the key enzyme in the inﬂammatory re-
sponse. Although both ac-LDL and ox-LDL trigger inﬂamma-
tory response in macrophages, OFC maintain high levels of
IL1b expression, whereas AFC displayed only transient induc-
tion. The current study provided valuable lists for genes that
are common or unique for AFC and OFC. Further study for
the genes and function might prove beneﬁcial to the pathogen-
esis of atherosclerosis.
Fig. 3. Real-time RT-PCR showing time-course expression of ENGL2, AKT1, PCTK1, and JAG2 in AFC and OFC. Data is plotted based on
DDCt. The fold expression is equal to 2
DDCt . Each data point are the mean of three independent measurements and is expressed as means ± S.E.M.
Asterisks depict signiﬁcant diﬀerences between AFC and OFC. Solid bars, AFC; open bars, OFC.
Fig. 4. Real-time RT-PCR and time-course experiments for the
expression of interleukin 1beta in ac-LDL- and ox-LDL-laden foam
cells. The fold expression is equal to 2DDC. Each data point are the
mean of three independent measurements and is expressed as means ±
S.E.M. Asterisks depict signiﬁcant diﬀerences between AFC and OFC
(\P < 0.05; \\P < 0.01). Filled circle, AFC; open circle, OFC.
Fig. 5. IL1b protein level secreted by the cholesterol-loaded THP-1
cell ELISA was performed to the culture media of AFC and OFC in a
time course experiment. Each data point are the mean of three
independent measurements and is represented as the means ± S.E.M.
Filled circle, AFC; open circle, OFC.
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Fig. 6. Generation of free radicals following addition of ac-LDL and
ox-LDL to macrophages. Fluorescence intensities are derived from
image analysis; they are normalized against THP-1 cells and expressed
as a percentage of the ﬂuorescence intensities of OFC on day 3. Each
data point are the mean of three independent measurements and is
represented as the means ± S.E.M. Asterisks depict signiﬁcant diﬀer-
ences between AFC and OFC (\P < 0.05; \\P < 0.01). Filled circle,
AFC; open circle, OFC.
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